All In MedTech

Device Trial Radar · NCT03758521

Natural History Study of Patients With Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency

Last checked: Nov 19, 2026Latest source record: Jan 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

55

Planned (sponsor's estimate)

Start

Jan 15, 2019

Primary completion

May 31, 2029

Study completion Jun 2029

Sponsor

Lead sponsor
Boston Children's HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Washington State University; University of South Florida; University Hospital Heidelberg; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
First posted
Nov 29, 2018

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Succinic Semialdehyde Dehydrogenase deficiency (SSADHD) is a rare autosomal recessive disease that interferes with the catabolism of the major inhibitory neurotransmitter gamma-amino butyric acid (GABA) and furthermore leads to accumulation of various potential toxic metabolites, most prominently gamma hydroxybutyric acid (GHB). Current research indicates that there is developmental delay and significant neurophysiological and biochemical alterations in SSADHD patients, but whether disease presentation varies with age is not known. The investigators propose to determine the natural course of the clinical presentation of SSADHD; to determine the natural course of neurophysiological and biochemical indices known to be altered in SSADHD; and to identify neurophysiological and biochemical predictors of clinical severity. The overall objective is to define the natural course of the clinical, neurophysiological and biochemical spectrum of SSADHD. Secondary objectives include the identification of biomarkers that correlate with disease phenotype and predict clinical outcomes, and the creation of an international SSADHD data repository for future investigation of pathogenesis and therapy.

Conditions

  • Succinic Semialdehyde Dehydrogenase Deficiency

Interventions

  • Transcranial magnetic stimulation (TMS)Device

    Transcranial magnetic stimulation (TMS) is a method for noninvasive electrical cortical stimulation, where small intracranial currents are generated by a powerful, fluctuating, extracranial magnetic field. TMS is unique in its capacity for experimental, diagnostic, and therapeutic utility. Single pulse (spTMS) and paired-pulse TMS (ppTMS) have been used extensively to study, measure, and modulate cortical excitability and plasticity.

  • Magnetic resonance imaging (MRI)Device

    These will be outpatient MRI studies that are planned without sedation. Subjects enrolled at BCH will undergo brain MRI, including volumetric MRI, MRS, and diffusion tensor imaging (DTI). The data will help define the natural history of brain volume, brain myelination and spectroscopic (e.g. GABA) abnormalities.

  • Electroencephalogram (EEG)Device

    These will be outpatient EEG recordings that span 20-60 minutes and done without sedation. Recordings will be performed using electrode locations specified by the international 10-20 system for standard clinical practice.

  • Bio-specimen CollectionProcedure

    Bio-specimen collection will include blood, urine, saliva, hair, stool, and a skin biopsy. Blood, urine, saliva, blood spots, and hair samples will also be banked for to-be-determined (TBD) studies.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical Severity ScoreTime frame: 5 Years
  2. Biochemical - GABA measurementTime frame: 5 Years
  3. Biochemical - GHB measurementTime frame: 5 Years

1 more outcomes with a free account

Locations

4 sites in 4 countries. Site status is shown where the registry gives one.

  • Boston Children's Hospital

    Boston, Massachusetts · Recruiting

  • University Children's Hospital

    Heidelberg, Heidelberg, Germany · Recruiting

  • Sant Joan de Deu Hospital Barcelona

    Barcelona, Spain · Active not recruiting

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.